| Indicators | Browse All

Omnicell, Inc. (OMCL)

Healthcare | Health Information Services | Fort Worth, United States | NasdaqGS
45.94 USD -0.74 (-1.585%) ⇩ (July 14, 2026, 4 p.m. EDT)

Short-term:★★★★☆Long-term:★★★☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:11 a.m. EDT

The immediate outlook is aggressively bullish, driven by a powerful technical rebound and overwhelming speculative positioning. The stock has staged a remarkable recovery, climbing nearly 70% over the last year to erase previous declines, and the options market is screaming for further gains with heavy call buying at distant strikes. However, this rally is occurring against a backdrop of historically poor fundamentals; the company trades at a staggering forward P/E of over 20x despite generating only 1.6% return on equity and minimal profit margins. The disconnect between the exuberant price action and the weak underlying profitability suggests the current surge is priced on momentum and narrative rather than value. While the short-term trend remains strongly upward, investors should be wary of buying at these elevated levels without a catalyst to justify the premium over intrinsic value.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.045977
AutoTheta0.048145
AutoETS0.048349
AutoARIMA0.048393

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 37%
H-stat 15.48
Ljung-Box p 0.000
Jarque-Bera p 0.146
Excess Kurtosis -0.69
Attribute Value
Sector Healthcare
Debt to Equity Ratio 16.089
Revenue per Share 26.838
Market Cap 2,089,300,992
Trailing P/E 104.41
Forward P/E 20.93
Beta 0.97
Profit Margins 1.67%
Website https://www.omnicell.com

As of July 11, 2026, 3:11 a.m. EDT: Speculators are overwhelmingly bullish, evidenced by massive open interest in out-of-the-money calls (OTM OI % > 80% across expirations) compared to negligible put activity. The heavy concentration of call volume at strikes significantly above the current price (e.g., $60, $65, $70) suggests a strong expectation of a substantial upside move, while the lack of defensive put positioning indicates low fear of a downside crash.


Info Dump

Attribute Value
52 Week Change 0.7136564
Address1 4,220 North Freeway
All Time High 187.29
All Time Low 1.29
Ask 57.67
Ask Size 2
Audit Risk 2
Average Analyst Rating 1.4 - Strong Buy
Average Daily Volume10 Day 594,020
Average Daily Volume3 Month 658,950
Average Volume 658,950
Average Volume10Days 594,020
Beta 0.966
Bid 33.1
Bid Size 2
Board Risk 5
Book Value 27.632
City Fort Worth
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 2
Country United States
Crypto Tradeable 0
Currency USD
Current Price 45.94
Current Ratio 1.495
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 46.7834
Day Low 44.75
Debt To Equity 16.089
Display Name Omnicell
Earnings Call Timestamp End 1,785,414,600
Earnings Call Timestamp Start 1,785,414,600
Earnings Timestamp 1,785,414,600
Earnings Timestamp End 1,785,414,600
Earnings Timestamp Start 1,785,414,600
Ebitda 73,610,000
Ebitda Margins 0.060089998
Enterprise To Ebitda 27.88
Enterprise To Revenue 1.675
Enterprise Value 2,052,260,096
Eps Current Year 1.9375
Eps Forward 2.195
Eps Trailing Twelve Months 0.44
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 42.365
Fifty Day Average Change 3.574997
Fifty Day Average Change Percent 0.08438562
Fifty Two Week Change Percent 71.36565
Fifty Two Week High 55.0
Fifty Two Week High Change -9.060001
Fifty Two Week High Change Percent -0.1647273
Fifty Two Week Low 26.85
Fifty Two Week Low Change 19.089998
Fifty Two Week Low Change Percent 0.7109869
Fifty Two Week Range 26.85 - 55.0
Financial Currency USD
First Trade Date Milliseconds 997,363,800,000
Float Shares 41,937,012
Forward Eps 2.195
Forward P E 20.929384
Free Cashflow 112,564,376
Full Exchange Name NasdaqGS
Full Time Employees 3,525
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.43873
Gross Profits 537,470,016
Has Pre Post Market Data 1
Held Percent Insiders 0.02251
Held Percent Institutions 1.0548999
Implied Shares Outstanding 45,478,909
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Long Name Omnicell, Inc.
Market us_market
Market Cap 2,089,300,992
Market State PRE
Max Age 86,400
Message Board Id finmb_32401
Most Recent Quarter 1,774,915,200
Net Income To Common 20,433,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 2,122,955,472
Number Of Analyst Opinions 7
Open 46.43
Operating Cashflow 155,876,000
Operating Margins 0.054390002
Overall Risk 5
Payout Ratio 0.0
Peg Ratio 15.4
Phone 877 415 9990
Previous Close 46.68
Price Eps Current Year 23.710966
Price Hint 2
Price To Book 1.6625651
Price To Sales Trailing12 Months 1.7054725
Profit Margins 0.01668
Quick Ratio 1.042
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.375
Region US
Regular Market Change -0.7400017
Regular Market Change Percent -1.5852649
Regular Market Day High 46.7834
Regular Market Day Low 44.75
Regular Market Day Range 44.75 - 46.7834
Regular Market Open 46.43
Regular Market Previous Close 46.68
Regular Market Price 45.94
Regular Market Time 1,784,059,200
Regular Market Volume 655,541
Return On Assets 0.01207
Return On Equity 0.01626
Revenue Growth 0.149
Revenue Per Share 26.838
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 45,478,909
Shares Percent Shares Out 0.0699
Shares Short 3,177,748
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 2,973,198
Short Name Omnicell, Inc.
Short Percent Of Float 0.0848
Short Ratio 4.07
Source Interval 15
State TX
Symbol OMCL
Target High Price 70.0
Target Low Price 55.0
Target Mean Price 61.28571
Target Median Price 60.0
Total Cash 239,220,992
Total Cash Per Share 5.26
Total Debt 202,180,000
Total Revenue 1,225,057,024
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.44
Trailing P E 104.40909
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 39.52115
Two Hundred Day Average Change 6.41885
Two Hundred Day Average Change Percent 0.16241556
Type Disp Equity
Volume 655,541
Website https://www.omnicell.com
Zip 76,137